Zurich Cantonal Bank
ANIP icon

Zurich Cantonal Bank’s ANI Pharmaceuticals ANIP Stock Holding History

Zurich Cantonal Bank’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,971
Closed -$235K – 2610
2025
Q4 		$235K Buy
+2,971
New +$257K ﹤0.01% 2172

Other funds holding ANIP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Zurich Cantonal Bank's ANIP Position: Q1 2026 in Review

Zurich Cantonal Bank opened a new position in ANI Pharmaceuticals (ANIP) in Q1 2026: 4,285 shares worth $330K. The stake represents ﹤0.01% of the portfolio and ranks #2049 among its holdings. This is a return to the name: Zurich Cantonal Bank previously reported a position in ANIP as recently as Q3 2025.

Zurich Cantonal Bank first reported a position in ANIP in Q3 2015 and has held it in 42 quarters since. 280 funds tracked by Wall St. Rank hold ANIP as of Q1 2026.

  • Zurich Cantonal Bank held 4,285 shares of ANI Pharmaceuticals worth $330K as of Q1 2026.
  • ANI Pharmaceuticals was a new Zurich Cantonal Bank position in Q1 2026.
  • ANI Pharmaceuticals made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q1 2026, its #2049 holding.
  • Zurich Cantonal Bank first reported a position in ANI Pharmaceuticals in Q3 2015 and has held it in 42 quarters since.
  • 280 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2026.

Based on Zurich Cantonal Bank's 13F filing for Q1 2026, filed 15 May 2026.